PathMaker Neurosystems company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

pmneuro.com

Founded Year

2015

Stage

Grant - III | Alive

Total Raised

$100K

Last Raised

$100K | 2 mos ago

About PathMaker Neurosystems

PathMaker Neurosystems is a clinical-stage neuromodulation company developing non-invasive systems for the treatment of paralysis, muscle weakness, and spasticity found in patients with neuromotor disorders, such as stroke, cerebral palsy, multiple sclerosis, spinal cord injury, traumatic brain injury, Parkinson's disease, and other neurological disorders. The company serves clients operating in the healthcare sector. It was founded in 2015 and is based in Boston, Massachusetts.

PathMaker Neurosystems Headquarter Location

One International Place Suite 1400

Boston, Massachusetts, 02110,

United States

617-535-7696

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

PathMaker Neurosystems Patents

PathMaker Neurosystems has filed 1 patent.

The 3 most popular patent topics include:

  • Disability sport classifications
  • Neurological disorders
  • Rare diseases
patents chart

Application Date

Grant Date

Title

Related Topics

Status

10/21/2019

Neurological disorders, Disability sport classifications, Rare diseases, Syndromes, SUNY community colleges

Application

Application Date

10/21/2019

Grant Date

Title

Related Topics

Neurological disorders, Disability sport classifications, Rare diseases, Syndromes, SUNY community colleges

Status

Application

Latest PathMaker Neurosystems News

PathMaker Neurosystems Receives $100K START Award from MassVentures

Jun 13, 2022

PathMaker Neurosystems Inc (PathMaker) , a near-commercial stage neuromodulation company developing breakthrough non-invasive systems for the treatment of serious neurological disorders, was selected as a recipient of a START award from MassVentures, which funds deep tech startups based in Massachusetts as they advance technology developed under NIH SBIR/STTR funding. This Stage I START funding was awarded on the basis of PathMaker’s $4.9M grant from the NINDS Cooperative Research to Enable and Advance Translational Enterprises for Devices (CREATE Devices) program to develop MyoRegulator, a first-in-class, non-invasive neuromodulation device for treating muscle spasticity. “We are very pleased to have the support from MassVentures for our efforts to commercialize the MyoRegulator product,” said Nader Yaghoubi, MD, PhD, President and Chief Executive Officer of PathMaker. “With our EU pivotal trial successfully completed and our US multi-center pivotal trial underway, we are excited about the next phase of our company’s growth.” MassVentures is a venture capital firm that helps transfer research and early-stage innovations into technology businesses and jobs in Massachusetts. The  MassVentures START program  helps deep tech startups convert their Small Business Innovation and Small Business Technology Transfer research (SBIR/STTR) into businesses and jobs in Massachusetts. The $100,000 MassVentures START award will enable additional transfer-to-manufacturing work on MyoRegulator as PathMaker approaches commercial launch of its first product. [Source(s): PathMaker Neurosystems Inc, GlobeNewswire] Share:

PathMaker Neurosystems Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

PathMaker Neurosystems Rank

  • When was PathMaker Neurosystems founded?

    PathMaker Neurosystems was founded in 2015.

  • Where is PathMaker Neurosystems's headquarters?

    PathMaker Neurosystems's headquarters is located at One International Place, Boston.

  • What is PathMaker Neurosystems's latest funding round?

    PathMaker Neurosystems's latest funding round is Grant - III.

  • How much did PathMaker Neurosystems raise?

    PathMaker Neurosystems raised a total of $100K.

  • Who are the investors of PathMaker Neurosystems?

    Investors of PathMaker Neurosystems include MassVentures, New England Pediatric Device Consortium and Bpifrance.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.